Pinpoint Medical

PinPoint Medical is a UK-based medical technology company established in 2018 that specializes in developing advanced diagnostic and environmental monitoring solutions. The company utilizes proprietary biosensing technology and nano-scale detection systems to address critical challenges in healthcare, including rapid, non-invasive prostate cancer screening and the monitoring of airborne pathogens. Their primary technology platform, the Advanced Disposable Plasmonic Assay (DPA) biosensor, is designed for high-precision, real-time detection of multiple infectious agents. This sensor technology is integrated into their intelligent Air Quality (iAQ) platform, a modular system engineered to clean air and monitor for disease-related pathogens in clinical, laboratory, and public environments.

By focusing on early detection and real-time environmental management, PinPoint Medical aims to improve patient outcomes and enhance public safety. Their solutions offer a cost-effective, high-throughput alternative to traditional, more expensive diagnostic methods, helping clinicians and facilities maintain safer environments. The company, led by CEO Jason Donnelly and CTO Dr. Affar Karimullah, combines research expertise in nanotechnology and biomedical engineering to develop its product ecosystem. Their work is supported by a multi-disciplinary team that manages the end-to-end development of sensors, readers, and software platforms for automated reporting and infection control.